Zach Rossfeld
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zach Rossfeld has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Samantha Grable
Palliative Medicine, OhioHealth, Columbus, Ohio, USA
2 shared publications Adam R. Ketner
Departments of Pediatrics and
1 shared publicationAndrea Wetshtein
Department of Pharmacy, Cleveland Clinic Fairview Hospital, Cleveland, Ohio, USA
1 shared publication- Brianna Burns
Service Line Analytics, OhioHealth, Columbus, Ohio, USA
1 shared publication David D. Fosselman
Departments of Pediatrics and
1 shared publication- Dmitry Tumin
Department of Pediatrics, Brody School of Medicine, East Carolina University, Greenville, NC, USA
1 shared publication
Latest Publications
- 1 July 2024
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 27 (7) , 846-853
Observations from Optimizing an Electronic Order Set for Withdrawal of Life-Sustaining Treatment
Background: Withdrawal of life-sustaining treatment (WLST) is a process with unique pressure for all involved. The use of an electronic order set can facilitate best care. Objective: To assess utilization of a WLST order set and time to inpatient death before and after optimization. Design: A retrospective chart review for 12-month periods before and after enhancements to a WLST order set. Setting/Subjects: Multicenter study within an American, not-for-profit health care system of inpatient decedents July 2017–June 2018 and April 2021–March 2022 with orders placed via WLST order set. Measurements: Co-primary outcomes included order set utilization and time from activation of orders to patient death. Descriptive post hoc analyses featured demographics, palliative consultation, ordering clinician type/specialty, and COVID-19. Results: A total of 1949 patients had orders placed via the WLST order set and died in-hospital. Compared with the 2017–2018 period, use increased 35.8% in 2021–2022. Time to death after release of orders was significantly longer for the 2021–2022 group (4.4 vs. 3.7 hours). Demographic details included nurse practitioners (39%) as most frequent WLST order set utilizer and palliative consultation in 46% of terminal hospitalizations. Among decedents with consultation, palliative clinicians were the WLST order set utilizer for 47% of cases (i.e., 21% of all WLST order set utilizations). The median time to death was significantly longer when orders were placed by a palliative clinician (4.5 hours) compared with nonpalliative specialists (3.9 hours). COVID-19 was a hospital diagnosis for 29% of decedents in the 2021–2022 group. Conclusions: In the emotionally and cognitively intense process that is WLST, an order set provides a modifiable panel of defaults. Our experience highlights the power in guiding primary palliative care for WLST in the hospital setting and suggests that advanced practice providers and nonpalliative clinicians, as primary utilizers, be integral in the design of a WLST order set.
- 1 July 2024
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 27 (7) , 846-853
Observations from Optimizing an Electronic Order Set for Withdrawal of Life-Sustaining Treatment
Background: Withdrawal of life-sustaining treatment (WLST) is a process with unique pressure for all involved. The use of an electronic order set can facilitate best care. Objective: To assess utilization of a WLST order set and time to inpatient death before and after optimization. Design: A retrospective chart review for 12-month periods before and after enhancements to a WLST order set. Setting/Subjects: Multicenter study within an American, not-for-profit health care system of inpatient decedents July 2017–June 2018 and April 2021–March 2022 with orders placed via WLST order set. Measurements: Co-primary outcomes included order set utilization and time from activation of orders to patient death. Descriptive post hoc analyses featured demographics, palliative consultation, ordering clinician type/specialty, and COVID-19. Results: A total of 1949 patients had orders placed via the WLST order set and died in-hospital. Compared with the 2017–2018 period, use increased 35.8% in 2021–2022. Time to death after release of orders was significantly longer for the 2021–2022 group (4.4 vs. 3.7 hours). Demographic details included nurse practitioners (39%) as most frequent WLST order set utilizer and palliative consultation in 46% of terminal hospitalizations. Among decedents with consultation, palliative clinicians were the WLST order set utilizer for 47% of cases (i.e., 21% of all WLST order set utilizations). The median time to death was significantly longer when orders were placed by a palliative clinician (4.5 hours) compared with nonpalliative specialists (3.9 hours). COVID-19 was a hospital diagnosis for 29% of decedents in the 2021–2022 group. Conclusions: In the emotionally and cognitively intense process that is WLST, an order set provides a modifiable panel of defaults. Our experience highlights the power in guiding primary palliative care for WLST in the hospital setting and suggests that advanced practice providers and nonpalliative clinicians, as primary utilizers, be integral in the design of a WLST order set.
- 14 March 2024
- Published by Taylor & Francis in Journal of Pain & Palliative Care Pharmacotherapy
- Vol. 38 (2) , 149-152
Alpha Alert: Utilization of Transdermal Clonidine for Refractory Agitation
Alpha-2 agonists are under-recognized for their class effects yet offer potential benefit in specialty palliative care via decreasing sympathetic output, inducing sedation, and modulating pain. Especially in clinical contexts where agitation predominates and patients are intolerant of oral medication route, transdermal medication delivery is advantageous. We report a case of agitated behaviors in setting of mixed Alzheimer/vascular-type dementia limiting hospital discharge to nursing facility that were ameliorated with transdermal clonidine. We suggest palliative clinicians routinely conceptualize the seemingly disparate alpha-2 agonists as a class for effective symptom palliation especially as new clinical evidence becomes available.
- 14 March 2024
- Published by Taylor & Francis in Journal of Pain & Palliative Care Pharmacotherapy
- Vol. 38 (2) , 149-152
Alpha Alert: Utilization of Transdermal Clonidine for Refractory Agitation
Alpha-2 agonists are under-recognized for their class effects yet offer potential benefit in specialty palliative care via decreasing sympathetic output, inducing sedation, and modulating pain. Especially in clinical contexts where agitation predominates and patients are intolerant of oral medication route, transdermal medication delivery is advantageous. We report a case of agitated behaviors in setting of mixed Alzheimer/vascular-type dementia limiting hospital discharge to nursing facility that were ameliorated with transdermal clonidine. We suggest palliative clinicians routinely conceptualize the seemingly disparate alpha-2 agonists as a class for effective symptom palliation especially as new clinical evidence becomes available.
- Open Access
- 1 May 2019
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 9 (5) , 373-378
Timing of Palliative Consultation for Children During a Fatal Illness
BACKGROUND: The American Academy of Pediatrics recommends palliative care for children at the diagnosis of serious illness. Yet few children who die receive specialty palliative care consultation, and when it is provided, palliative care consultation tends to occur after >75% of the time from diagnosis until death. Focusing on the timing of palliative consultation in relation to the date of diagnosis, we evaluated factors predicting earlier receipt of pediatric palliative care in a cohort of decedents. METHODS: We retrospectively identified patients diagnosed with a life-limiting disease who died at our hospital in 2015–2017 after at least 1 inpatient palliative medicine consultation. Our primary outcome was time from palliative-qualifying diagnosis to earliest receipt of specialty palliative care. A survival analysis was used to describe factors associated with earlier receipt of palliative care. RESULTS: The analysis included 180 patients (median age at diagnosis <1 month [interquartile range (IQR): 0–77]). The median time to first palliative consultation was 7 days after diagnosis (IQR: 2–63), compared with a median of 50 days between diagnosis and death (IQR: 7–210). On the multivariable analysis, palliative consultation occurred earlier for patients who had cardiovascular diagnoses, had private insurance, and were of African American race. CONCLUSIONS: In a cohort of decedents at our institution, palliative consultation occurred much earlier than has been previously reported. We also identify factors associated with delayed receipt of palliative care among children who are dying that reveal further opportunities to improve access to specialty palliative care.
- 1 May 2019
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 9 (5) , 373-378
Open AccessTiming of Palliative Consultation for Children During a Fatal Illness
BACKGROUND: The American Academy of Pediatrics recommends palliative care for children at the diagnosis of serious illness. Yet few children who die receive specialty palliative care consultation, and when it is provided, palliative care consultation tends to occur after >75% of the time from diagnosis until death. Focusing on the timing of palliative consultation in relation to the date of diagnosis, we evaluated factors predicting earlier receipt of pediatric palliative care in a cohort of decedents. METHODS: We retrospectively identified patients diagnosed with a life-limiting disease who died at our hospital in 2015–2017 after at least 1 inpatient palliative medicine consultation. Our primary outcome was time from palliative-qualifying diagnosis to earliest receipt of specialty palliative care. A survival analysis was used to describe factors associated with earlier receipt of palliative care. RESULTS: The analysis included 180 patients (median age at diagnosis <1 month [interquartile range (IQR): 0–77]). The median time to first palliative consultation was 7 days after diagnosis (IQR: 2–63), compared with a median of 50 days between diagnosis and death (IQR: 7–210). On the multivariable analysis, palliative consultation occurred earlier for patients who had cardiovascular diagnoses, had private insurance, and were of African American race. CONCLUSIONS: In a cohort of decedents at our institution, palliative consultation occurred much earlier than has been previously reported. We also identify factors associated with delayed receipt of palliative care among children who are dying that reveal further opportunities to improve access to specialty palliative care.